Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Gene Editing In China: EdiGene Raises Fresh Funds, Aims For First IND
'Great Leap' From Gene-Edited Babies to One-Time Cures
Oct 15 2020
•
By
Brian Yang
GENE EDITING FIRM EDIGENE RAISES NEW FUNDS, PLANS FIRST IND IN CHINA • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia